Cranberry Chemical recorded pretax restructuring charges of $1378 million in 2014. The charges consisted of asset write-downs of $908 million, costs associated with exit or disposal activities of $132 million, and employee severance costs of $338 million. The company paid $144 million cash to settle these restructuring charges during the year (2014)

What was the restructuring accrual associated with these charges at the year end?